← Back to patent-cliff list
R2R01
Tier C — Watch / tradeR2R01
River 2 Renal Corp
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：RXFP1
Indications (approved)：急性肾损伤, Heart failure, 肝肾综合征
Regional status
US
Phase II
2023-06-30
EU
Phase II
2026-04-07
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of R2R01?
Approved indications include: 急性肾损伤, Heart failure, 肝肾综合征.
When does the R2R01 patent expire?
No public expiry year is available for R2R01 yet; this page updates once verified.
How do I get a quote for R2R01 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03